Niagen Bioscience Inc

NAGE | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.04

+$0.05 (+1.67%)

At close: Sep 21, 2026, 4:00 PM ET

$3.09

+$0.05 (+1.63%)

Pre-market: Sep 22, 2026, 7:04 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.67%

(1D)

Rating

Updated: Sep 19, 2026

52.5

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $242.12M

1D Range

2.97 3.04

52W Range

2.87 10.52

Valuation (TTM)

PE 16

PB 2.93

EV/EBITDA 9.62

Valuation (NTM)

Forward PE 17.66

Forward PEG 2.10

Price Target $10.33

Cash Flow

FCF Yield 2.3%

SBC Adj. FCF Yield -0.5%

SBC Impact -122.4%

Margins

Gross Margin 64.2%

Operating Margin 6.7%

FCF Margin 4.4%

Growth (CAGR)

Revenue 3Y | 5Y 16.8% | 15.8%

Dil EPS 3Y | 5Y 81.7% | 644.7%

FCF 3Y | 5Y 50.1% | 522.2%

Returns

ROA 15.0%

ROE 20.5%

ROIC 8.8%

Financial Health

Net Cash

$66.74M

Current Ratio 6.50

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It prov...

Sector Healthcare

Industry Biotechnology

Employees 117

IPO Date Jun 23, 2015

Website www.niagenbioscience.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$10

Upside

+228.95%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞